《復牌公告》美固科技(08349.HK)股東以2,472萬元出售30.9%持股 觸發全面要約
美固科技(08349.HK)公布,於今年3月31日,售股股東與要約人訂立買賣協議,龍祥國際投資同意出售1.236億股股份,佔公司全部已發行股本的30.9%,每股待售股份0.2元,較前收市價每股0.62元折讓約67.7%,總代價為2,472萬元。
計及要約人及其一致行動人士於去年收購的10%股權,交易完成後將持有1.636億股,佔已發行股份的40.9%。
根據收購守則規則26.1,於交易完成後,要約人須就所有已發行股份(要約人及其一致行動人士已擁有者除外)提出強制性有條件現金要約,每股要約作價現金0.2元,估計總代價將為4,728萬元。
公司已申請於今早九時正起恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.